BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
Release time:
2018-01-11
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA.
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
October 27th, 2017—BrosMed Medical announced CE Mark and Launched its Wedge™ Scoring PTCA Balloon for the treatment of percutaneous transluminal coronary angioplasty (PTCA) for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
As a part of BrosMed Medical balloon catheter portfolio, Wedge™ Semi-complaint Scoring PTCA balloon is designed to satisify clinical needs which current cutting/scoring PTCA not met. The aim of Wedge™ Semi-Compliant Scoring PTCA balloon would be simply treated as workhorse PTCA for small/difussed/calcified lesion which would maximally eliminate dissection with minimal slippage phenomena. Featuring the smallest available balloon diameter of 1.5 mm, lengths up to 30 mm, and comprehensive configurations including quarter-size increments, Wedge™ provides more clinical choices than conventional scoring balloons.
According to the company, Wedge™ is rapid exchange PTCA balloon catheter that requires limited training to the physicians and it will not alter physicians’ current practice. Wedge™ PTCA would be used like conventional PTCA. Constructed with engineered material, the Wedge™ Semi-complaint Scoring PTCA catheter has consistent rated burst pressures of 14atm from φ1.5 to φ4.0mm.
We believe that the launch of Wedge™ Scoring PTCA will be a game-changer for the current scoring PTCA market, thanks to its unique design derived from first-hand physician experience. It is simple and effective for physicians’ daily work and would reduce the hesitation of using scoring PTCA due to its crossability.” said by Stephen Lee, General Manager of BrosMed Medical.
“The launch of Wedge™ Scoring PTCA will definitely differentiate us from our competitors and enhance the BrosMed brand in the market. Besides our excellent Artimes™ and Apollo™ NC PTCA, we have new products entering the market, and we believe they will further elevate our reputation,” said by Jos A.W.J de Korte, General Manager of BrosMed Medical B.V., the Netherlands, marketing and sales center of BrosMed Medical in Europe.
Please contact our regional distributors and/or our sales at sales@brosmed.com or cs@brosmed.eu or office +31 850 14 09 01 for more products details.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
BrosMed Medical product portfolio consist of, Artimes™ PTCA, Apollo™ NC PTCA, Wedge™ Semi-complaint Scoring PTCA, Atropos™ 0.035 PTA, Minerva™ 0.018 PTA, Polux™ 0.014 PTA, Hermes™ NC 0.035 PTA, Achilles™ NC 0.018 PTA, Castor™ NC 0.014 PTA, Conger™ Hydrophilic coated guidewire and Freepath™ Catheter Sheath Introducer. BrosMed Medical is supplying safe, effective and hi-tech medical devices in 30 countries.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
